In a patient with suspected left renal artery stenosis, what is the appropriate imaging workup and subsequent management?

Imaging Workup and Management of Suspected Left Renal Artery Stenosis

For a patient with suspected left renal artery stenosis, proceed with duplex Doppler ultrasound as the initial screening test if the patient has normal renal function, or CT angiography/MR angiography if ultrasound is technically limited or if you need definitive anatomic imaging before considering intervention. 1

Initial Imaging Strategy

The choice of imaging modality depends primarily on renal function and local expertise:

Duplex Doppler Ultrasound (First-Line Screening)

• Use when: Patient has any level of renal function, as it requires no contrast 1
• Key diagnostic criteria:
  • Peak systolic velocity (PSV) ≥200 cm/s (sensitivity 73-91%, specificity 75-96%) 1
  • Renal artery to aortic ratio (RAR) ≥3.5 1
  • For higher specificity, use PSV threshold of 300 cm/s 1
  • Indirect signs: Parvus-tardus waveform with acceleration time >70 milliseconds 1

Critical limitation: Ultrasound is highly operator-dependent and may be limited by body habitus, bowel gas, or inability to visualize the entire renal artery 1. If technically inadequate, proceed directly to CTA or MRA.

CT Angiography or MR Angiography (Definitive Anatomic Imaging)

• Use when:
  • Ultrasound is technically limited or inconclusive
  • You need precise anatomic detail before planning intervention
  • Patient has normal renal function (for CTA) 1
• Performance: Both have sensitivity 90-94% and specificity 93-94% 2
• Advantages: Can identify accessory renal arteries, assess aortic disease, and evaluate for other causes of secondary hypertension (pheochromocytoma) 1

For impaired renal function: Use non-contrast MRA protocols to avoid nephrogenic systemic fibrosis and contrast-induced nephropathy 1

Avoid Captopril Renal Scintigraphy

Sensitivity ranges only 34-93% and is particularly poor in bilateral disease or impaired renal function 1. This modality has largely been supplanted by cross-sectional imaging.

Management Algorithm

Step 1: Confirm Hemodynamic Significance

Not all anatomic stenoses are functionally significant. A stenosis must be ≥70-75% to reduce perfusion pressure and cause renovascular hypertension 1. The ultimate criterion is blood pressure improvement after intervention 1.

Step 2: Screen for Secondary Hypertension

Before considering revascularization, evaluate for other causes of secondary hypertension 3. Look for these clinical features suggesting renovascular hypertension:

• Abdominal bruit
• Hypertension onset <35 years (suggests fibromuscular dysplasia) or >50 years
• Malignant/accelerated hypertension (DBP >110 mmHg)
• Sudden worsening of previously controlled hypertension
• Refractory hypertension despite ≥3 medications
• Renal function deterioration with ACE inhibitors 1

Step 3: Medical Management First

Optimize medical therapy before considering revascularization 4, 5:

• Goal-directed antihypertensive therapy (ACE inhibitors/ARBs + CCB + thiazide diuretics)
• Lipid-lowering therapy
• Smoking cessation
• Antiplatelet therapy

Critical caveat: Randomized trials (including ASTRAL) have failed to show benefit of revascularization over medical management alone for most patients with atherosclerotic RAS 4, 6.

Step 4: Consider Revascularization Only in Select Cases

Indications for intervention:

• Fibromuscular dysplasia (balloon angioplasty without stent is treatment of choice) 4, 7
• Recurrent flash pulmonary edema
• Progressive renal dysfunction despite medical therapy
• Truly refractory hypertension (stage 2 hypertension on ≥4 medications at optimal doses) 3
• Bilateral RAS or stenosis to a solitary functioning kidney with declining function 8

Absolute contraindications to revascularization:

• Renal artery stenosis itself is a contraindication to renal denervation procedures 3
• Small, atrophic kidney (<7-8 cm) suggests irreversible damage
• Resistive index >0.80 may predict poor response (though this is debated) 1

Step 5: Post-Intervention Surveillance

If revascularization is performed, surveillance imaging with duplex ultrasound, CTA, or MRA is mandatory 3:

• Highest risk of restenosis is within first 6 months (0.2% per year overall) 3
• For stented arteries, use higher thresholds: PSV ≥395 cm/s or RAR ≥5.1 1
• Restenosis occurs in 14-20% of cases and is more common with stent diameter ≤5 mm, vasculitis, and lack of initial BP/renal function improvement 9

Key Clinical Pitfalls

1. Don't assume anatomic stenosis equals clinical disease: Many patients have incidental RAS without renovascular hypertension 4, 6

2. Atherosclerotic RAS rarely benefits from stenting: The 2025 AHA/ACC guidelines emphasize that significant renal artery stenosis is a contraindication to renal denervation, highlighting that the presence of RAS requires careful evaluation rather than automatic intervention 3

3. Distinguish atherosclerotic disease (90% of cases, typically ostial) from fibromuscular dysplasia (10%, typically mid-to-distal vessel): Treatment approaches differ fundamentally 1

4. Bilateral disease is difficult to assess: Hard to determine which side is responsible for hypertension 1